DRTECH Corporation

214680KOSDAQMedical, precision and optical instruments

DRTECH Corporation (214680, KOSDAQ) reported KRW 116bn revenue in 2025.

Reported financials

Figures are as filed with the Korean regulator, in billions of won (KRW bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported.

YearRevenueOperating profitNet profitAssetsEquityBasis
202392-0-216485Consolidated
202498-12-1917973Consolidated
2025116-14-2420277Consolidated

Ratios, year by year

Each ratio is computed inside its own year. A dash means the input was missing or the denominator was zero — not that the value is zero.

YearOperating marginNet marginEquity / assetsReturn on equity
2023-0.2%-2.2%51.6%-2.4%
2024-12.4%-19.8%40.6%-26.5%
2025-11.9%-20.7%38%-31.3%

Revenue moved 25.8% between 2023 and 2025.

These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.

Market size

Market capitalisationKRW 80bn
Close priceKRW 960
Listed shares83,477,056
Price as of20260909

Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.

Workforce — a side measure, not the main one

Employees (2025)381
Women76 (19.9%)
Average tenure4 years
Annual pay, menKRW 54,000,000
Annual pay, womenKRW 45,000,000
Pay ratio, women to men83.3%

Other companies in Medical, precision and optical instruments

102 listed companies file under this classification. Showing 12.

See the whole Medical, precision and optical instruments list →